Similar articles

• Enhancement of antibiotic concentrations in gastric mucosa by H2-receptor antagonist. Implications for treatment of Helicobacter pylori infections.

  Westblom TU, Duriex DE. Westblom TU, et al. Dig Dis Sci. 1991 Jan;36(1):25-8. doi: 10.1007/BF01300082. Dig Dis Sci. 1991. PMID: 1985000
• Guinea pig model for antibiotic transport across gastric mucosa: inhibitory tissue concentrations of clindamycin against Helicobacter pylori (Campylobacter pylori) following two separate dose regimens.

  Westblom TU, Duriex DE, Madan E, Belshe RB. Westblom TU, et al. Antimicrob Agents Chemother. 1990 Jan;34(1):25-8. doi: 10.1128/AAC.34.1.25. Antimicrob Agents Chemother. 1990. PMID: 2327758 Free PMC article.
• Mucosal concentration and excretion of clindamycin by the human stomach.

  Hextall A, Radley S, Andrews JM, Boyd EJ, Dent JC, Donovan I, Wise R. Hextall A, et al. J Antimicrob Chemother. 1994 Mar;33(3):595-602. doi: 10.1093/jac/33.3.595. J Antimicrob Chemother. 1994. PMID: 8040123
• [Histologic, culture and breath test detection methods and therapy of Campylobacter pylori colonization of the stomach].

  Rauws EA, Langenberg W, Houthoff HJ, Tytgat GN. Rauws EA, et al. Z Gastroenterol. 1987 Sep;25 Suppl 4:24-8. Z Gastroenterol. 1987. PMID: 3318190 Review. German. No abstract available.
• Clindamycin.

  Klainer AS. Klainer AS. Med Clin North Am. 1987 Nov;71(6):1169-75. doi: 10.1016/s0025-7125(16)30804-5. Med Clin North Am. 1987. PMID: 3320618 Review.